AMETEK Acquires Rauland-Borg Corporation

BERWYN, Pa., Feb. 7, 2017 /PRNewswire/ — AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Rauland-Borg Corporation, a leading global provider of mission critical communication solutions for hospitals, healthcare systems and educational facilities. Rauland-Borg was acquired for $340 million, plus a potential contingent payment of $30 million tied to the achievement... Read more

Announcement on submission of the Clinical Trial Plan Notification for phase II clinical trial of Oncolytic virus HF10 in Japan

2017 2017/01/30 Announcement on submission of the Clinical Trial Plan Notification for phase II clinical trial of Oncolytic virus HF10 in Japan Kusatsu/Shiga, Japan — January 30, 2017 — Takara Bio Inc. (Takara Bio), today announced that the Clinical Trial Notification was submitted to PMDA (Pharmaceuticals and Medical Devices Agency; Japanese regulatory agency) to conduct... Read more

Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of NY-ESO-1・siTCR gene therapy in Japan

2017 2017/01/24 Announcement on submission of the Clinical Trial Plan Notification for phase I/II clinical trial of NY-ESO-1・siTCR gene therapy in Japan Kusatsu/Shiga, Japan — January 24, 2017 — Takara Bio Inc. (Takara Bio), today announced that it has submitted the Clinical Trial Notification for regenerative medicines to PMDA (Pharmaceuticals and Medical Devices Agency), Japanese... Read more

Enzo Life Sciences Launches New Compound Library to Provide Essential Standards for Cancer Inhibitor Screening

Enzo Life Sciences is proud to introduce the SCREEN-WELL® Cancer Library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL® Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains... Read more

Gyros Protein Technologies appoints Gerrit van den Dool to Board of Directors

Uppsala, Sweden, 19 January 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, announced today the appointment of Gerrit van den Dool to its Board of Directors, as a Non-Executive Director. With more than 25 years’ experience in the life science industry and with his... Read more

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

WARREN, N.J., Jan. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will assume the... Read more

Congenica Expands in North America with Strategic Appointment

Congenica Expands in North America with Strategic Appointment Shikha O’Brien, Chief Business Officer Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer 16th January 2017, Cambridge UK Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha... Read more

Extending Ultrasound’s Impact: GE Healthcare’s New Vscan Extend Empowers Clinicians in Critical Moments

London – 11 January 2017 – Bringing ultrasound care into every setting in any environment  around the globe1, GE Healthcare today unveiled its new generation of pocket-sized, dual-probe ultrasound, the Vscan Extend™2. From the hospital and ambulance to more rural environments1, Vscan Extend™ uses incredible image quality and wireless connectivity3  to help users increase clinical... Read more